Under Armour continues to be an innovator in athletic apparel. Outlook Strategies Why I’m bullish on Under Armour
Biotech stocks tend to outperform in times of economic expansion. Strategies Why I added Amgen and Celgene to my portfolio
Market choppiness will be the norm not exception. Strategies Get ready for more stock market volatility
My portfolio felt the broader declines in consumer stocks. Strategies Tough times for consumer stocks
A correction looks probable, but long-term outlook is strong. Strategies Four reasons a stock market correction is likely
By any number of measures this market is getting pricey. Strategies Six charts that show why this market is overvalued
South African and South Korea have potential long term. Strategies Emerging market stocks and debt look attractive in 2014
Developing markets were crushed in 2013. This year they're back. Strategies Emerging market stocks offer value in 2014
I hold winners for the long term in this portfolio. Strategies Looking back at two years of Sustained Momentum portfolio
Covestor Manager Freedland looks back on his record. Strategies Looking back on almost five years with Covestor
Just like in hoops, it's important to take the long view in investing. Strategies Investing lessons from LeBron James
Here's a look at my ETF strategy heading into the new year. Strategies 2014 ETF strategy: industrials, healthcare and consumer brands
